Initial trials of PLX4032 suggest it may be as good as, or even better than, ipilimumab at improving sufferers' survival. A full-scale, double-blind trial is now under way.
最初的PLX4032的试验证明它在延长患者生命方面同ipilimumab一样好，甚至比ipilimumab更好，全规模的双盲试验目前正在进行中。
Methods We conducted a multicenter, randomized, double-blind trial involving nulliparous women who were at low risk for preeclampsia.
方法我们进行了一项多中心、随机、双盲试验，纳入先兆子痫危险低的未经产妇女。
Methods Multi-center randomized double-blind trial with positive control and split-mouth comparison was designed.
方法多中心随机、双盲、阳性药物对照、左右半口对照设计。
Methods Multi-center randomized double-blind trial with positive control and split-mouth comparison was designed.
方法多中心随机、双盲、阳性药物对照、左右半口对照设计。
应用推荐